BNN QUARTERLY 03/2024 “Moving towards Sustainability in the Pharmaceutical Sector”

Dear colleagues and friends,

The BNN QUARTERLY is out, with our latest issue entitled “Moving towards Sustainability in the Pharmaceutical Sector“.  We are pleased to highlight the following focus topic-related contributions:

• BioNanoNet Annual Forum & Joint Networking Session 2024 on “Sustainability in Pharma” Was a Great Success
• PHOENIX Webinar: A New Player Bridging Nano-Pharmaceutical Innovation from Design to Clinic
• Interview: BNN Provides Regulatory Expertise to Biotech Company Aromics
• Green Pharmaceuticals from Lignin: A Sustainable Revolution in the Pharma Industry
• SSbD Meets Multifunctional Biomaterials: BNN Visits NABIHEAL Partner University of Maribor
• Enzymes Instead of Cyanide: Researchers Develop Biocatalytic Process for Nitrile Production
• Driving Sustainability and Efficiency in Drug Discovery: Leveraging Enalos Asclepios KNIME Nodes for In Silico Advancements
• PharmECO Project Proposal Approved
• COMET Module Twin4Pharma – Digital and Green (Twin) Transition of Pharmaceutical Product and Process Development

Besides scientific contributions from our BioNanoNet Association Members, reports about projects and activities, this issue also includes a presentation and an interview of our member:

• OCSiAL Europe S.a.r.l. (Luxembourg): OCSiAl is the world’s largest manufacturer of graphene nanotubes, owning the only scalable technology capable of synthesizing them in industrial volumes.

We hope you enjoy this edition!

Sincerely,
BNN team

P.S.: Are you not yet receiving our BNN QUARTERLY? Subscribe here!